A team from PNNL contributed several articles to the Domestic Preparedness Journal showcasing recent efforts to explore the emergency management and artificial intelligence research and development landscape.
PNNL’s year in review includes highlights ranging from advancing soil science to understanding Earth systems, expanding electricity transmission, detecting fentanyl, and applying artificial intelligence to aid scientific discovery.
The Pacific Northwest Association of Toxicologists (PANWAT) presented its annual Toxicology Achievement Award to Katrina Waters at the Society of Toxicology Pacific Northwest Chapter Meeting, held in Lynnwood, Washington, on September 30th.
The National Transmission Planning Study presents several transmission expansion scenarios that would reliably support the growing demand for energy across the nation.
PNNL biodefense experts seek to identify, understand and mitigate the risks of biological pathogens—whether naturally occurring or intentionally created—so steps can be taken to prepare and respond.
Early life exposure to polycyclic aromatic hydrocarbons (PAHs), found in smoke, has been linked to developmental problems. To study the impacts of these pollutants, PAH metabolism in infants and adults were compared.
At the National Homeland Security Conference, researchers shared how partnerships and emerging technologies like artificial intelligence can play a key role in emergency management preparedness and response.
PNNL advisors joined a panel of Washington State emergency management personnel to discuss how partnerships with national laboratories are enabling science and technology solutions.
At the GovAI Summit 2023, Ryan Eddy joined the Department of Homeland Security Science and Technology Directorate on a panel highlighting artificial intelligence impacts and opportunities in the field of emergency management.
A team of researchers received an award for their contributions to improving the operational readiness and safety posture of the firefighter community by conducting a rigorous evaluation of commercially available equipment.
Scientists screen for nanobodies that recognize wild type and mutant functional proteins to develop a framework to disrupt protein interactions that can cause disease.
